通过简短动机干预加短信改善结核结局的生活方式行为研究方案
该研究为在南非三省开展的多中心双臂个体随机对照试验,评估由非专业卫生工作者实施的动机性访谈加短信的行为干预对药物敏感肺结核患者结核治疗成功及生活方式相关结局的效果与成本效果,计划招募696名成年吸烟和/或有害饮酒的患者。
要点
- 干预为三次动机性访谈加每周两次短信,针对治疗依从性、饮酒和吸烟。
- 主要结局为基于WHO定义的结核治疗成功,随访至6个月。
- 若有效且具成本效果,该方案可能对全球结核治疗具有重要启示。
核心结论
- 该研究旨在评估ProLife综合行为干预对改善结核治疗成功及生活方式相关结局的有效性和成本效果。
研究设计与样本
- 前瞻性、多中心、双臂个体随机对照试验,在南非三个省的27家诊所连续招募696名18岁及以上药物敏感肺结核且当前吸烟和/或报告有害或危险饮酒的成年患者。
主要发现
- 原文未报告研究结果。
关键数值与推荐
- 干预组接受三次动机性访谈咨询(每次间隔一个月),每次访谈后每周两次短信,针对治疗依从性、饮酒和吸烟。
- 主要结局为使用WHO标准结核治疗结局定义评估的结核治疗成功。
- 次要结局包括戒烟、减少饮酒、结核药物和抗逆转录病毒治疗依从性,在3个月和6个月随访时测量。
临床怎么用
- 若ProLife方案被证实有效且具成本效果,可在广泛的结核治疗环境中实施。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: South Africa is among the seven highest tuberculosis (TB) burden countries. Harmful lifestyle behaviours, such as smoking and alcohol, and poor adherence to medication can affect clinical outcomes. Modification of these behaviours is likely to improve TB treatment outcomes and has proven possible using motivational interviewing (MI) techniques or use of short message service (SMS) text messaging. There have been no studies assessing the effect of combined MI and SMS interventions on multiple lifestyle factors and TB treatment outcomes. METHODS: This is a prospective, multicentre, two-arm individual randomised controlled trial looking at the effectiveness and cost-effectiveness of a complex behavioural intervention (the ProLife programme) on improving TB and lifestyle-related outcomes in three provinces of South Africa. The ProLife programme consists of an MI counselling strategy, delivered by lay health workers, augmented with subsequent SMS. We aim to recruit 696 adult participants (aged 18 years and over) with drug-sensitive pulmonary TB who are current smokers and/or report harmful or hazardous alcohol use. Patients will be consecutively enrolled at 27 clinics in three different health districts in South Africa. Participants randomised individually to the intervention arm will receive three MI counselling sessions one month apart. Each MI session will be followed by twice-weekly SMS messages targeting treatment adherence, alcohol use and tobacco smoking, as appropriate. We will assess the effect on TB treatment success, using standard World Health Organization (WHO) treatment outcome definitions (primary outcome), as well as on a range of secondary outcomes including smoking cessation, reduction in alcohol use, and TB medication and anti-retroviral therapy adherence. Secondary outcomes will be measured at the three-month and six-month follow-ups. DISCUSSION: This trial aligns with the WHO agenda of integrating TB care with the care for chronic diseases of lifestyle, such as provision of smoking cessation treatments, and with the use of digital technologies. If the ProLife programme is found to be effective and cost-effective, the programme could have significant implications for TB treatment globally and could be successfully implemented in a wide range of TB treatment settings. TRIAL REGISTRATION: ISRCTN Registry, ISRCTN62728852. Registered on 13 April 2018.
引用
- Moriarty AS, Louwagie GM, Mdege ND, et al. ImPROving TB outcomes by modifying LIFE-style behaviours through a brief motivational intervention followed by short text messages (ProLife): study protocol for a randomised controlled trial. Trials. 2019. PMID: 31349850. doi:10.1186/s13063-019-3551-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。